AIDS

1. FILIP I
   Effect of statins on blood pressure provides added cardioprotective benefit for individuals with HIV.
   AIDS. 2026 Jun 5. doi: 10.1097/QAD.0000000000004558.
   

   >> Share

   
   
2. MENDES DE LEON KF, Klungers RD, Nieuwkerk PT, Van Der Valk M, et al
   Willingness to switch to long-acting regimens among people with HIV: a systematic review and meta-analysis.
   AIDS. 2026 Jun 4. doi: 10.1097/QAD.0000000000004556.
   

   >> Share

   
   
3. MOUSSAOU ME, Ladang A, Maes N, Cavalie E, et al
   Heterogeneity of baseline immune activation and SARS-CoV-2 vaccine responses in people with HIV: a multicenter prospective study.
   AIDS. 2026 Jun 2. doi: 10.1097/QAD.0000000000004557.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

4. MUTENHERWA F, Lutalo T, Galiwango RM, Feltes JB, et al
   Perceived Ethical Risks of HIV Phylogenetic Research: Insights from Professional Stakeholders in Uganda.
   AIDS Res Hum Retroviruses. 2026 Jun 2:8892229261455943.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

5. CHEN Q, Luo Y, Zheng Q, Tan M, et al
   Efficacy and safety of doravirine/lamivudine/tenofovir as initial treatment for people living with HIV in China.
   Antimicrob Agents Chemother. 2026 Jun 4:e0007426. doi: 10.1128/aac.00074.
   

   >> Share

   
   

   
   Blood

6. 
   Tadagaki K, Tudor D, Gbahou F, et al. Human cytomegalovirus-encoded UL33 and UL78 heteromerize with host CCR5 and CXCR4 impairing their HIV coreceptor activity. Blood. 2012;119(21):4908-4918.
   Blood. 2026;147:2849.
   

   >> Share

   
   

   
   BMC Cancer

7. MALANGWA G, Banzi MO, Makupa G, Nnko G, et al
   The social and clinical profile of patients with ocular surface squamous cell carcinoma in Tanzania.
   BMC Cancer. 2026 May 30. doi: 10.1186/s12885-026-16178.
   

   >> Share

   
   

   
   BMC Pediatr

8. PENDA CI, Eboumbou PE, Ngondi GD, Anaba SJN, et al
   Impact of optimized antiretroviral therapy on virological and nutritional outcomes among HIV infected adolescents in Cameroon.
   BMC Pediatr. 2026 May 30. doi: 10.1186/s12887-026-07046.
   

   >> Share

   
   

   
   Clin Infect Dis

9. KILLANDER MOLLER I, Brannstrom J, Elvstam O, Gisslen M, et al
   Renal Risk and Creatinine Elevation in People With HIV - Broadening the Perspective.
   Clin Infect Dis. 2026 Jun 2:ciag340. doi: 10.1093.
   

   >> Share

   
   
10. MANESH A, Aslan AT, Mohan George M, Sulaiman H, et al
    Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.
    Clin Infect Dis. 2026;82.
    

    >> Share

    
    
11. BERENGUER J, Ryan P, Lutz T, Martin-Carbonero L, et al
    Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.
    Clin Infect Dis. 2026 Jun 1:ciag341. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

12. RAO D, Inescu OM, Sabin CA, Sandulescu O, et al
    Models of care for women living with HIV in Europe: A scoping review.
    HIV Med. 2026 Jun 5. doi: 10.1111/hiv.70266.
    

    >> Share

    
    
13. ZIMMERMANN HML, Stutterheim SE, van Beckhoven D, Vanden Berghe W, et al
    Differences in HIV testing may determine the first pillar of the HIV care continuum in a cross-border setting.
    HIV Med. 2026 Jun 4. doi: 10.1111/hiv.70263.
    

    >> Share

    
    
14. NICHOLAS R, Alford K, Fitzpatrick C, Vera J, et al
    Screening for bone health in older people with HIV: Uptake and outcomes from a large UK outpatient HIV service.
    HIV Med. 2026 Jun 2. doi: 10.1111/hiv.70264.
    

    >> Share

    
    
15. RAUSCHNING D, Ike AME, Holterhoff J, Stockinger A, et al
    HIV drug resistance and treatment success in the Republic of Congo: Implications for optimized treatment.
    HIV Med. 2026 May 29. doi: 10.1111/hiv.70261.
    

    >> Share

    
    

    
    Immunology

16. FORTUIN TL, Nkone P, Loubser S, Tiemessen CT, et al
    Characterisation of HIV-1 Gag Cytotoxic T-Lymphocyte Epitopes in the Southern African Region-A Systematic Review.
    Immunology. 2026 May 31. doi: 10.1111/imm.70156.
    

    >> Share

    
    

    
    J Immunol

17. 
    Correction to: Combinatorial action of TGFbeta and IL-10 induces monocyte and monocyte-derived dendritic cell dysfunction in people living with HIV 3717.
    J Immunol. 2026;215:vkag047.
    

    >> Share

    
    

    
    J Infect Dis

18. BOURGI K, Bian A, Boyd L, Gupta SK, et al
    Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and Canada.
    J Infect Dis. 2026 May 29:jiag271. doi: 10.1093.
    

    >> Share

    
    
19. ILLESCAS-LOPEZ M, Munoz P, de Salazar A, Delgado R, et al
    HIV-1 APOBEC-context mutations detected by next-generation sequencing in plasma: implications for drug resistance interpretation.
    J Infect Dis. 2026 Jun 4:jiag277. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

20. CHEN Y, Lan Y, Zhao A, Zhang Y, et al
    Anti-Zika Virus Activity of Azvudine via Inhibition of RNA Replication by Its Active Triphosphate Form.
    J Med Virol. 2026;98:e71000.
    

    >> Share

    
    
21. MUNGALE A, Behnia M, Dremel SE, Ziegelbauer JM, et al
    Vascular Endothelial Growth Factor Receptor 2 (VEGFR2/KDR) Promotes KSHV Lytic Replication and Drives Pro-Inflammatory Cytokine Release and Cancer Signaling.
    J Med Virol. 2026;98:e70989.
    

    >> Share

    
    

    
    J Virol

22. PANCHAPAKESAN A, Joshi AP, Amanullah A, Pargain N, et al
    Enhanced strand transfer and mismatch extension by HIV-1C reverse transcriptase promote sequence motif duplication.
    J Virol. 2026 Jun 4:e0052626. doi: 10.1128/jvi.00526.
    

    >> Share

    
    

    
    Lancet Infect Dis

23. 
    Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet Infect Dis. 2026 Jun 2:S1473-3099(26)00194.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

24. CINAR EN, Markowich AH, Vergadi E, Lyall H, et al
    Duration of Postnatal HIV Prophylaxis: How Long Is Long Enough?
    Pediatr Infect Dis J. 2026 Jun 2. doi: 10.1097/INF.0000000000005308.
    

    >> Share

    
    
25. KINKADE CW, Sheng Q, Peter O, Kumar A, et al
    Epigenetic Age Acceleration, Neurocognition and Oral Health in Nigerian Adolescents With and Without HIV.
    Pediatr Infect Dis J. 2026 Jun 3. doi: 10.1097/INF.0000000000005305.
    

    >> Share

    
    

    
    PLoS Med

26. LIU YE, Bampi JVB, Arthur RF, Salindri AD, et al
    Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling study.
    PLoS Med. 2026;23:e1004739.
    

    >> Share

    
    

    
    PLoS One

27. NASINGHE E, Musinguzi D, Takuwa M, Kamulegeya R, et al
    Tuberculosis in households with infectious cases in Kampala city: Harnessing health data science for new insights on an ancient disease with persistent, unresolved problems.
    PLoS One. 2026;21:e0348823.
    

    >> Share

    
    
28. DREYER AJ, Joska JA, Thomas KGF, Sabin C, et al
    The role of premorbid cognitive performance in the neuropsychological assessment of people with HIV in South Africa.
    PLoS One. 2026;21:e0349942.
    

    >> Share

    
    
29. POESCHLA A, Wele A, Nalintya E, Dai B, et al
    Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screening.
    PLoS One. 2026;21:e0349854.
    

    >> Share

    
    
30. EKWUNIFE O, Mangenah C, Ngwira L, Corbett E, et al
    Economic barriers to diagnostic equity: A multi-country analysis of patient costs for rapid SARS-CoV-2 testing in sub-Saharan Africa.
    PLoS One. 2026;21:e0350288.
    

    >> Share

    
    
31. TWEYA H, Thawani A, Klabbers R, Huwa J, et al
    Tracing the journey: Patient engagement in long-term antiretroviral therapy care in Malawi.
    PLoS One. 2026;21:e0323983.
    

    >> Share

    
    

    
    PLoS Pathog

32. MORAGA E, Climent N, Sanchez-Molina A, Vicens-Artes S, et al
    Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells.
    PLoS Pathog. 2026;22:e1014266.
    

    >> Share

    
    
33. MAHMOUD RM, Hiyoshi M, Abdelnaser RA, Monde K, et al
    M-Sec promotes the production of infectious HIV-1 virus through the exocyst complex in macrophages.
    PLoS Pathog. 2026;22:e1013717.
    

    >> Share

    
    

    
    Vaccine

34. VOLPI CR, Chama J, Adebiyi R, Aigoro JA, et al
    Understanding HPV vaccine preferences among sexual minority men living with HIV in Abuja, Nigeria using a discrete choice experiment.
    Vaccine. 2026;87:128771.
    

    >> Share

    
    
35. SHARMA A, Kerkhoff AD, Haambokoma M, Shamoya B, et al
    Corrigendum to "Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia" ["Vaccine 50 (2025) 126846].
    Vaccine. 2026 May 31:128757. doi: 10.1016/j.vaccine.2026.128757.
    

    >> Share

    
    
36. LE TOURNEAU N, Sharma A, Pry JM, Haambokoma M, et al
    Corrigendum to "Drivers of decision-making for future adult vaccines: a best-worst scaling among community members and health care workers in Zambia" [Vaccine 70 (2026) 128003].
    Vaccine. 2026;87:128756.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share